Bionano Genomics (BNGO) Change in Acquisitions & Divestments (2021 - 2026)

Bionano Genomics has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $54.1 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 6.76% year-over-year to $54.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $232.6 million (up 16.57% YoY) and the FY2025 annual result came in at $229.1 million, down 25.36% from the prior year.
• Change in Acquisitions & Divestments retreated to $54.1 million in Q1 2026 per BNGO's latest filing, from $68.4 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $158.2 million in Q1 2024 and troughed at $16.9 million in Q1 2023.
• A 5-year average of $54.6 million and a median of $52.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments soared 836.58% in 2024, then sank 67.95% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $65.5 million in 2022, then decreased by 20.38% to $52.2 million in 2023, then tumbled by 58.4% to $21.7 million in 2024, then jumped by 215.1% to $68.4 million in 2025, then decreased by 20.82% to $54.1 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $54.1 million, $68.4 million, and $56.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.